A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Conditions:   Overweight;   ObesityInterventions:   Drug: pramlintide acetate;   Drug: sibutramine;   Drug: phentermine;   Drug: placeboSponsor:   AstraZenecaCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials